Mountainfield Venture Partners
Overview
Mountainfield Venture Partners is a biopharmaceutical company creation firm that builds new companies around development-stage drug candidates with the potential to transform patient care.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Timberlyne Therapeutics | Jan 2025 | Series A | Co-investor |
| cAMPfield Therapeutics | Jun 2026 | Series A | Co-investor |
Key People
Daniel Curran
Managing Partner
David Socks
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mountainfield Venture Partners based?
Mountainfield Venture Partners is headquartered in San Diego, California, United States.
When was Mountainfield Venture Partners founded?
Mountainfield Venture Partners was founded in 2024.
How many portfolio companies does Mountainfield Venture Partners have?
Mountainfield Venture Partners has 2 portfolio companies in Caplight's dataset.
What are some companies in Mountainfield Venture Partners's portfolio?
Portfolio companies visible on Caplight include Timberlyne Therapeutics, cAMPfield Therapeutics.
What was Mountainfield Venture Partners's most recent investment shown here?
Mountainfield Venture Partners's most recent investment in this portfolio sample was in cAMPfield Therapeutics in 2026.
What sectors does Mountainfield Venture Partners focus on?
Mountainfield Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Mountainfield Venture Partners focus on?
Mountainfield Venture Partners typically invests at the Early stage.